Cellectis Reports Financial Results for Third Quarter and First Nine Months 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Cellectis (CLLS) Tops Q3 EPS by 26c
November 6, 2019 5:23 PM ESTCellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.54), $0.26 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $3.28 million.
The third quarter of 2019 has been essential for our execution strategy, as we achieved a series of important key... More
